Log in to save to my catalogue

Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies

Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3b35be841d7946ce86f766c27d628451

Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies

About this item

Full title

Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies

Publisher

Switzerland: MDPI AG

Journal title

Medicina (Kaunas, Lithuania), 2022-04, Vol.58 (5), p.612

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The use and interpretation of diagnostic cerebrospinal fluid (CSF) biomarkers for neurodegenerative disorders, such as Dementia with Lewy bodies (DLB), represent a clinical challenge. According to the literature, the composition of CSF in DLB patients varies. Some patients present with reduced levels of amyloid, others with full Alzheimer Disease C...

Alternative Titles

Full title

Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3b35be841d7946ce86f766c27d628451

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3b35be841d7946ce86f766c27d628451

Other Identifiers

ISSN

1648-9144,1010-660X

E-ISSN

1648-9144

DOI

10.3390/medicina58050612

How to access this item